NECTIN2 and neoplasm: TIGIT is expressed by activated T-cells, NK cells, and Tregs [92], and its ligands include CD112 (NECTIN2) and CD155 (Necl-5) [83], which are expressed by tumor cells and APCs within the tumor microenvironment (TME) [93,94].